DNA Methylation, a Hand Behind Neurodegenerative Diseases

Overview

Journal Front Aging Neurosci

Specialty Geriatrics

Date 2013 Dec 25

PMID 24367332

Citations 70

Authors

Haoyang Lu

Xinzhou Liu

Yulin Deng

Hong Qing

Affiliations

Soon will be listed here.

Abstract

Epigenetic alterations represent a sort of functional modifications related to the genome that are not responsible for changes in the nucleotide sequence. DNA methylation is one of such epigenetic modifications that have been studied intensively for the past several decades. The transfer of a methyl group to the 5 position of a cytosine is the key feature of DNA methylation. A simple change as such can be caused by a variety of factors, which can be the cause of many serious diseases including several neurodegenerative diseases. In this review, we have reviewed and summarized recent progress regarding DNA methylation in four major neurodegenerative diseases: Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS). The studies of these four major neurodegenerative diseases conclude the strong suggestion of the important role DNA methylation plays in these diseases. However, each of these diseases has not yet been understood completely as details in some areas remain unclear, and will be investigated in future studies. We hope this review can provide new insights into the understanding of neurodegenerative diseases from the epigenetic perspective.

Citing Articles

DNA methylation, histone acetylation in the regulation of memory and its modulation during aging.

Singh P, Paramanik V Front Aging. 2025; 5():1480932.

PMID: 39835300 PMC: 11743476. DOI: 10.3389/fragi.2024.1480932.

Retinal prolactin isoform PRLΔE1 sustains rod disease in inherited retinal degenerations.

Sudharsan R, Kwok J, Swider M, Sumaroka A, Aguirre G, Cideciyan A Cell Death Dis. 2024; 15(9):682.

PMID: 39294136 PMC: 11410941. DOI: 10.1038/s41419-024-07070-1.

Influence of DNA Methylation on Vascular Smooth Muscle Cell Phenotypic Switching.

Yorn C, Kim H, Jeong K Int J Mol Sci. 2024; 25(6).

PMID: 38542110 PMC: 10969885. DOI: 10.3390/ijms25063136.

Integrative Analysis Unveils the Correlation of Aminoacyl-tRNA Biosynthesis Metabolites with the Methylation of the Gene in Huntington's Disease Brain Tissue.

Vishweswaraiah S, Yilmaz A, Saiyed N, Khalid A, Koladiya P, Pan X Genes (Basel). 2023; 14(9).

PMID: 37761892 PMC: 10530570. DOI: 10.3390/genes14091752.

Utility of DNA Methylation as a Biomarker in Aging and Alzheimer's Disease.

Milicic L, Porter T, Vacher M, Laws S J Alzheimers Dis Rep. 2023; 7(1):475-503.

PMID: 37313495 PMC: 10259073. DOI: 10.3233/ADR-220109.

References

PENN N, SUWALSKI R, ORiley C, Bojanowski K, YURA R . The presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid. Biochem J. 1972; 126(4):781-90. PMC: 1178489. DOI: 10.1042/bj1260781. View

Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman P, Rogers J . Epigenetic changes in Alzheimer's disease: decrements in DNA methylation. Neurobiol Aging. 2009; 31(12):2025-37. PMC: 2962691. DOI: 10.1016/j.neurobiolaging.2008.12.005. View

Fuso A, Seminara L, Cavallaro R, Danselmi F, Scarpa S . S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol Cell Neurosci. 2004; 28(1):195-204. DOI: 10.1016/j.mcn.2004.09.007. View

Ding Q, Markesbery W, Chen Q, Li F, Keller J . Ribosome dysfunction is an early event in Alzheimer's disease. J Neurosci. 2005; 25(40):9171-5. PMC: 6725754. DOI: 10.1523/JNEUROSCI.3040-05.2005. View

Lahiri D, Zawia N, Greig N, Sambamurti K, Maloney B . Early-life events may trigger biochemical pathways for Alzheimer's disease: the "LEARn" model. Biogerontology. 2008; 9(6):375-9. PMC: 4841617. DOI: 10.1007/s10522-008-9162-6. View

Silva P, Gigek C, Leal M, Bertolucci P, De Labio R, Payao S . Promoter methylation analysis of SIRT3, SMARCA5, HTERT and CDH1 genes in aging and Alzheimer's disease. J Alzheimers Dis. 2008; 13(2):173-6. DOI: 10.3233/jad-2008-13207. View

Duan W, Ladenheim B, Cutler R, Kruman I, Cadet J, Mattson M . Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. J Neurochem. 2002; 80(1):101-10. DOI: 10.1046/j.0022-3042.2001.00676.x. View

Morahan J, Yu B, Trent R, Pamphlett R . A genome-wide analysis of brain DNA methylation identifies new candidate genes for sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009; 10(5-6):418-29. DOI: 10.3109/17482960802635397. View

Villar-Menendez I, Blanch M, Tyebji S, Pereira-Veiga T, Albasanz J, Martin M . Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease. Neuromolecular Med. 2013; 15(2):295-309. DOI: 10.1007/s12017-013-8219-0. View

10.

de Lau L, Breteler M . Epidemiology of Parkinson's disease. Lancet Neurol. 2006; 5(6):525-35. DOI: 10.1016/S1474-4422(06)70471-9. View

11.

Richter J, Appenzeller S, Ammerpohl O, Deuschl G, Paschen S, Bruggemann N . No evidence for differential methylation of α-synuclein in leukocyte DNA of Parkinson's disease patients. Mov Disord. 2012; 27(4):590-1. DOI: 10.1002/mds.24907. View

12.

Bakulski K, Dolinoy D, Sartor M, Paulson H, Konen J, Lieberman A . Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. J Alzheimers Dis. 2012; 29(3):571-88. PMC: 3652332. DOI: 10.3233/JAD-2012-111223. View

13.

Siegmund K, Connor C, Campan M, Long T, Weisenberger D, Biniszkiewicz D . DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS One. 2007; 2(9):e895. PMC: 1964879. DOI: 10.1371/journal.pone.0000895. View

14.

Kriaucionis S, Heintz N . The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science. 2009; 324(5929):929-30. PMC: 3263819. DOI: 10.1126/science.1169786. View

15.

Mastroeni D, McKee A, Grover A, Rogers J, Coleman P . Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease. PLoS One. 2009; 4(8):e6617. PMC: 2719870. DOI: 10.1371/journal.pone.0006617. View

16.

Desplats P, Spencer B, Coffee E, Patel P, Michael S, Patrick C . Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases. J Biol Chem. 2011; 286(11):9031-7. PMC: 3059002. DOI: 10.1074/jbc.C110.212589. View

17.

Voutsinas G, Stavrou E, Karousos G, Dasoula A, Papachatzopoulou A, Syrrou M . Allelic imbalance of expression and epigenetic regulation within the alpha-synuclein wild-type and p.Ala53Thr alleles in Parkinson disease. Hum Mutat. 2010; 31(6):685-91. DOI: 10.1002/humu.21248. View

18.

Furuya T, da Silva P, Payao S, Rasmussen L, De Labio R, Bertolucci P . SORL1 and SIRT1 mRNA expression and promoter methylation levels in aging and Alzheimer's Disease. Neurochem Int. 2012; 61(7):973-5. DOI: 10.1016/j.neuint.2012.07.014. View

19.

Lahut S, Omur O, Uyan O, Agim Z, Ozoguz A, Parman Y . ATXN2 and its neighbouring gene SH2B3 are associated with increased ALS risk in the Turkish population. PLoS One. 2012; 7(8):e42956. PMC: 3423429. DOI: 10.1371/journal.pone.0042956. View

20.

Hood S, Cassidy P, Cossette M, Weigl Y, Verwey M, Robinson B . Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors. J Neurosci. 2010; 30(42):14046-58. PMC: 6634752. DOI: 10.1523/JNEUROSCI.2128-10.2010. View